Update on Clinical Research Summit in US Jay MoskowitzJames N. Thompson Current Opinion 22 September 2012 Pages: 149 - 150
The Role of Clinical Pathways in Reducing the Economic Burden of Stroke Douglas J. Lanska Leading Article 22 September 2012 Pages: 151 - 158
Reporting Format for Economic Evaluation Mark J. C. NuijtenMark J. A. BrorensMarja H. Pronk Leading Article 22 September 2012 Pages: 159 - 163
Cost Effectiveness of Prophylaxis for Opportunistic Infections in AIDS Kenneth A. FreedbergA. David Paltiel Review Article 22 September 2012 Pages: 165 - 173
A Review of the Pharmacoeconomics of Pharmaceutical Care Richard J. PlumridgeRichard E. Wojnar-Horton Review Article 22 September 2012 Pages: 175 - 189
Choice of NSAID and Management Strategy in Rheumatoid Arthritis and Osteoarthritis Chris J. McCabeRon L. AkehurstIan Haslock Original Research Article 22 September 2012 Pages: 191 - 199
Quality of Life Following a Change in Therapy for Diabetes Mellitus Mirjana Pibernik-OkanovićSilvija SzaboŽeljko Metelko Original Research Article 22 September 2012 Pages: 201 - 207
Cost Effectiveness of Screening for Subclinical Hypothyroidism in the Elderly Massimo BonaFerruccio SantiniRoberto Grilli Original Research Article 22 September 2012 Pages: 209 - 216
Pravastatin Allan J. CoukellMichelle I. Wilde Adis Pharmacoeconomic Drug Evaluation 22 September 2012 Pages: 217 - 236